Clinical aspects of ACE inhibition in patients with acute myocardial infarction

Cardiovascular Drugs and Therapy

Volumn 10, Issue 5, 1996, Pages 519-525

  Borghi, Claudio ^a,b   Ambrosioni, Ettore ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

ACE inhibitors; Angiotensin converting enzyme inhibitors; Heart failure; Myocardial infarction

Indexed keywords

CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOSINOPRIL; LISINOPRIL; RAMIPRIL; TRANDOLAPRIL; ZOFENOPRIL;

ACUTE HEART INFARCTION; ARTICLE; CONGESTIVE HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REVASCULARIZATION; HEART REINFARCTION; HIGH RISK PATIENT; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MORTALITY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CONTROLLED CLINICAL TRIALS; HUMANS; MYOCARDIAL INFARCTION;

EID: 0029906654     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00050991     Document Type: Article

References (44)

1. Yusuf S, Sleight P, Held P, McMahon S. Routine medical management of acute myocardial infarction: Lessons from overviews of recent randomized controlled trials. Circulation 1990;82(Suppl II):II117-II134.
2. McAlpine HM, Morton JJ, Leckie B, Rumley A, Gillen G, Dargie HJ. Neuroendocrine activation after acute myocardial infarction. Br Heart J 1988;60:117-124.
3. Tan LB, Jalil JE, Pick R, Janicki JS, Weber KT. Cardiac myocite necrosis induced by angiotensin II. Circ Res 1991; 69:1185-1195.
4. White HD, Norris RM, Brown MA, Brandt PWT, Withlock RML, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987;76:44-51.
5. Latini R, Maggioni AP, Flather M, Sleight P, Tognoni G. ACE-inhibitor use in patients with myocardial infarction. Summary of evidence from clinical trials. Circulation 1995; 92:3131-3137.
6. Pfeffer MA, Braunwald E, Moyè LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992;327:669-677.
7. Swedberg K, Held P, Kjekshus J, et al. Effect of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). N Engl J Med 1992;327:678-684.
8. Clough DP, Collis MG, Conway J, Hatton R, Keddie JR. Interaction of angiotensin-converting enzyme inhibitors with the function of the sympathetic nervous system. Am J Cardiol 1982;49:1410-1414.
9. The GISSI-3 Investigators. Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994;343:1115-1122.
10. ISIS-4 Collaborative Group. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial. Lancet 1995;345:669-685.
11. Ambrosioni E, Borghi C, Magnani B, on behalf of the SMILE Study Investigators. The effect of the angiotensin-converting-enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. N Engl J Med 1995:332;80-85.
12. Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction: Interim report from the Chinese Cardiac Study (CCS-1). Lancet 1995;345: 686-687.
13. The AIRE Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342:821-828.
14. Kober L, Torp-Pedersen C, Carlsen JE, et al. for the Trandolapril Cardiac Evaluation (TRACE) Study Group. A clinical trial of the angiotensin-converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995;333: 1670-1676.
15. Oldroyd KG, Pye MP, Ray SG, et al. Effects of early captopril administration on infarct expansion, left ventricular remodeling, and exercise capacity after acute myocardial infarction. Am J Cardiol 1991;68:713-718.
16. Flather M, Pipilis A, Collins R, et al. Randomised controlled trial of oral captopril, of oral isosorbide mononitrate, and of intravenous magnesium sulphate started early in acute myocardial infarction: Safety and hemodynamic effects. Eur Heart J 1994;15:608-619.
17. Latini R, Avanzini F, De Nicolao A, Rocchetti M for GISSI 3 Investigators. Effects of lisinopril and nitroglycerin on blood pressure early after myocardial infarction: The GISSI 3 pilot study. Clin Trials Therap 1995;56:680-692.
18. Kingma JH, van Gilst WH, Peels CH, et al. Acute intervention with captopril during thrombolysis in patients with first anterior myocardial infarction. Results from the CATS Study. Eur Heart J 1994;15:898-907.
19. Ambrosioni E, Borghi C, Magnani B for the SMILE Pilot Study Working Party. Early treatment of acute myocardial infarction with angiotensin-converting enzyme inhibition: Safety considerations. Am J Cardiol 1991;68:101D-110D.
20. Garg R, Yusuf S for the Collaborative Group on ACE-Inhibitor Trials. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 273;18:1450-1456.
21. GISSI-3 Investigators. Effect of lisinopril treatment on early mortality in patients with acute myocardial infarction and different risk profile: Data from the GISSI-3 study (abstract). J Am Coll Cardiol 1996;27(Suppl A):82A.
22. Ertl G, Kloner RA, Waine Alexander R, Braunwald E. Limitation of experimental infarct size by angiotensin-converting enzyme inhibitors. Circulation 1982;65:40-48.
23. Westlin W, Mullane K. Does captopril attenuate reperfusion-induced myocardial disfunction by scavenging free radicals? Circulation 1988;77(Suppl I):I30-I39.
24. Sogaard P, Gotzsche C-O, Ravkilde J, Thygesen K. Effects of captopril on ischemia and dysfunction of the left ventricle after myocardial infarction. Circulation 1993;87:1093-1099.
25. Wright R, Flapan AD, Simpson CC, Stenhouse F, Oliver F, Ludiam CA, Fox KAA. Effects of captopril on endogeneous flbrinolysis in patients with recent myocardial infarction. A double-blind randomised placebo controlled cross-over study (abstr). J Am Coll Cardiol 1994;1A:484A.
26. Ridker PM, Gaboury CL, Camlin PR, et al. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Circulation 1993;87:1969-1973.
27. van Gust WH, De Graeff PA, de Leeuw MJ, Scholtens E, Wesseling H. Converting enzyme inhibitors and the role of the sulfhydryl group in the potentiation of exo- and endogeneous nitrovasodilators. J Cardiovasc Pharmacol 1991; 18:429-436.
28. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effects of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 1988;319:80-86.
29. Sharpe N, Smith H, Murphy J, Hannan S. Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet 1988;1:255-259.
30. Sharpe N, Smith H, Murphy J, Greaves S, Hart H, Gamble G. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin converting enzyme inhibition. Lancet 1991;337:872-876.
31. Ambrosioni E, Borghi C, Magnani B for the SMILE Pilot Study Working Party. Early treatment of acute myocardial infarction with angiotensin-converting enzyme inhibition: Safety considerations. Am J Cardiol 1991;68:101D-110D.
32. Bonaduce D, Petretta M, Arrichiello P, et al. Effects of captopril treatment on left ventricular remodeling and function after anterior myocardial infarction: Comparison with digitalis. J Am Coll Cardiol 1992;19:858-863.
33. Bazzino O, Navarro Estrada J, Sosa Liprandi A, et al. Early treatment with low dose enalapril prevents left ventricular dilatation after acute myocardial infarction (abstr). Circulation 1992;86:I313.
34. Caidahl K, Bonarjee V, Carstensen S, et al. Effects of early angiotensin converting enzyme inhibition on left ventricular volumes in acute myocardial infarction (abst). Circulation 1992;86:I536.
35. Galcera-Tomas J, Nuno-De La Rosa JA, Torres-Martinez G, et al. Effects of early use of captopril on hemodynamics and short-term ventricular remodelling in acute anterior myocardial infarction. Eur Heart J 1993;14:259-266.
36. Kyriakidis MK, Petropulakis PN, Georgiou EK, et al. The effects of early captopril treatment on left ventricular volumes and function in patients with and without depressed global ejection fraction after acute myocardial infarction. Eur Heart J 1993;14:1692-1700.
37. Sogaard P, Gotzsche C-O, Ravkilde J, Thygesen K. Effects of captopril on ischemia and dysfunction of the left ventricle after myocardial infarction. Circulation 1993;87:1093-1099.
38. Ray SG, Pye M, Oldroyd KG, et al. Early treatment with captopril after acute myocardial infarction. Br Heart J 1993; 69:215-222.
39. Gueret P, Himbert P, Massabuau P, et al. The effects of early administration of captopril on left ventricular remodeling after acute myocardial infarction are related to infarct size. In: Proceedings of the 2nd International Symposium on ACE-Inhibitors, Amsterdam, 1993:229.
40. Schulman S, Gerstenblith G, Guerci A, et al. Effect of early therapy on left ventricular volumes in acute myocardial infarction (abstr). J Am Coll Cardiol 1993;21:370A.
41. Kingma JH, van Gilst WH, Peels CH, et al. Acute intervention with captopril during thrombolysis in patients with first anterior myocardial infarction. Results from the CATS study. Eur Heart J 1994;15:898-907.
42. Sogaard P, Nogaard A, Gotzsche CO, Ravkilde J, Thygesen K. Therapeutic effects of captopril on ischemia and dysfunction of the left ventricle after Q-wave and non-Q-wave myocardial infarction. Am Heart J 1994;127:1-7.
43. Hochman JS, Srichai MB, Picard M, et al. Very early ACE-inhibition reduces progressive left ventricular dilatation when t-PA fails to establish early reperfusion during acute anterior myocardial infarction (abstr). Circulation 1994;90: 1-19.
44. Ambrosioni E, Borghi C, Marino P, Zardini P, Magnani B. Fosinopril sodium in acute myocardial infarction. The FAMIS study (abstr). Eur Heart J 1994;15(abstract Suppl) 133.